Semaglutide May Reduce Knee Pain From Osteoarthritis

A powerful weight-loss medication may do more than reduce body weight. In a major clinical trial, semaglutide helped people with obesity and knee osteoarthritis lose weight and report less knee pain than participants who received a placebo. The findings suggest that treating obesity may improve joint symptoms as well as metabolic health. Source 1

The result matters because knee osteoarthritis can restrict walking, exercise, sleep, work, and everyday independence. People with obesity may face a difficult cycle: knee pain makes movement harder, reduced activity can contribute to further weight gain, and additional weight increases stress on the knee.

The study does not prove that semaglutide repairs damaged cartilage or cures osteoarthritis. It also does not mean that everyone with knee pain should take a weight-loss medication. The strongest evidence applies to people with obesity and painful knee osteoarthritis who meet medical criteria for treatment.

What Did the Study Find?

Researchers examined whether semaglutide could improve knee osteoarthritis symptoms in addition to producing substantial weight loss. The trial included 407 adults with obesity and knee osteoarthritis. Participants had an average age of approximately 56 years and an average body mass index of about 40, placing the group in the severe-obesity range.

Participants received either once-weekly semaglutide, increased to a dose of 2.4 milligrams, or a placebo. Both groups also received lifestyle counseling. The treatment period lasted 68 weeks.

Researchers measured body weight, knee pain, and physical function. Knee symptoms were assessed with the Western Ontario and McMaster Universities Osteoarthritis Index, commonly called WOMAC. This validated questionnaire measures pain, stiffness, and limitations in physical activity.

Main Results

People receiving semaglutide lost substantially more weight than those receiving placebo. Average weight loss was approximately 13.7% of initial body weight in the semaglutide group, compared with about 3.2% in the placebo group.

Knee pain also improved more with semaglutide. The semaglutide group reported an average WOMAC pain reduction of about 41.7 points, compared with approximately 27.5 points for the placebo group. Physical function improved as well.

The differences were statistically significant, meaning they were unlikely to have occurred by chance alone. The changes also appeared clinically relevant because participants reported lower pain scores and improved ability to move and function.

However, the results do not establish that semaglutide directly treats disease inside the knee. The improvement may have resulted largely from weight loss and reduced mechanical stress. Greater mobility, better metabolic health, and reduced inflammatory signaling may also have contributed.

What the Findings Do Not Prove

The study does not show that semaglutide:

• Regenerates damaged cartilage.
• Reverses osteoarthritis.
• Stops joint deterioration.
• Prevents knee replacement.
• Works for every type of knee pain.
• Produces lasting relief after treatment stops.
• Benefits people without obesity to the same extent.

The trial also cannot fully separate the effects of the medication from the effects of losing weight. A person taking semaglutide may experience several changes at once, including lower body weight, improved blood sugar regulation, greater ability to exercise, and changes in appetite and eating patterns.

Which Weight-Loss Drug Was Studied?

The medication studied was semaglutide, a glucagon-like peptide-1, or GLP-1, receptor agonist. It affects appetite and food intake and can improve blood sugar regulation. At the obesity-treatment dose, semaglutide is administered once weekly.

Semaglutide is not interchangeable with every other weight-loss medication. GLP-1 medicines and related incretin drugs have different dosing schedules, approved indications, clinical evidence, side effects, and eligibility requirements.

The study’s results should not automatically be applied to tirzepatide, newer multi-action medicines, or other obesity treatments. Eli Lilly’s research into multi-action obesity drugs may produce important findings for diabetes and weight management, but results from a diabetes trial do not prove that a medication treats knee osteoarthritis. Source 3

Why Might Weight Loss Relieve Knee Pain?

Reduced Mechanical Stress

The knee absorbs substantial force during ordinary activities. Walking, rising from a chair, climbing stairs, and carrying objects can place forces across the joint that exceed a person’s body weight.

When body weight decreases, the knee may experience less force during movement. Even moderate weight loss can make certain activities easier for some people, although the amount of pain relief varies.

The response depends on factors such as:

• Starting body weight.
• Osteoarthritis severity.
• Muscle strength.
• Joint alignment.
• Activity level.
• Previous injuries.
• Other sources of pain.

Weight is an important factor, but it is not the only explanation for knee osteoarthritis. Treatment should avoid blaming people for their condition and should address pain, mobility, general health, and personal goals.

Lower Inflammatory Signaling

Adipose tissue is biologically active. Excess adipose tissue can contribute to systemic inflammation and metabolic dysfunction. Weight loss may reduce some of these signals.

This mechanism is plausible, but it does not prove that semaglutide directly eliminates inflammation inside the knee. The trial showed improvements in symptoms and function; it did not establish cartilage regeneration or prove a specific local anti-inflammatory action in the joint.

Improved Mobility and Muscle Function

Knee pain often limits activity. Reduced activity can weaken the quadriceps, hip muscles, and other structures that help stabilize the knee. Weakness may increase difficulty with walking and stairs.

Weight loss may make movement more manageable. Increased movement can then improve muscle strength, balance, endurance, and confidence. Physical therapy, nutrition support, and appropriately paced exercise can also help create this beneficial cycle.

Knee Osteoarthritis and Body Weight

Osteoarthritis involves changes to cartilage, bone, the joint lining, and surrounding tissues. It is not simply the result of cartilage “wearing out,” and it is not an inevitable part of aging. Source 9

Common symptoms include:

• Pain during or after activity.
• Stiffness after rest.
• Swelling.
• Reduced range of motion.
• Difficulty climbing stairs.
• Difficulty walking for long periods.
• Grinding, clicking, or a sense of instability.

Risk factors include age, previous knee injury, joint alignment, genetics, occupation, activity patterns, and body weight.

Excess weight can affect the knees through mechanical and metabolic pathways. Greater body weight increases the load carried by weight-bearing joints. Obesity may also contribute to inflammation and make physical activity more difficult.

Still, body weight is only one contributor. Some people with obesity have little knee pain, while others with lower body weight develop osteoarthritis after injuries, because of genetics, or from other joint problems. A useful treatment plan focuses on improved function and quality of life rather than weight alone.

How Strong Is the Evidence?

Study Strengths

The trial had several important strengths:

• It was randomized and placebo-controlled.
• It included more than 400 participants.
• It used validated knee-pain and function measures.
• It measured both body weight and osteoarthritis symptoms.
• It followed participants for 68 weeks.
• It focused on people with obesity and clinically significant knee osteoarthritis.

These features make the results more reliable than anecdotal reports or uncontrolled studies.

Important Limitations

Pain is subjective. Expectations, mood, sleep, activity, and other treatments can influence pain scores. A clinical trial can measure these outcomes carefully, but it cannot remove every source of variation.

The follow-up period also does not answer several long-term questions. Researchers must determine whether pain relief continues with prolonged treatment, whether symptoms return after stopping semaglutide, and whether treatment affects the need for joint replacement.

The participants may not represent every patient seen in routine practice. The findings may not apply equally to:

• People without obesity.
• People with only mild overweight.
• People with advanced structural damage.
• People with inflammatory arthritis.
• People with knee pain caused by an injury.
• People with nerve, hip, or spine conditions that cause referred pain.

Pain Relief Is Not Disease Modification

A treatment can reduce pain without changing the underlying structure of the joint. Researchers distinguish between symptom relief, improved physical function, slower joint damage, and cartilage repair or regeneration.

The semaglutide trial supports symptom and function benefits. It does not establish cartilage repair or disease modification. Long-term imaging and follow-up are required to answer those questions.

Is Semaglutide Approved for Knee Osteoarthritis?

Semaglutide’s approved uses depend on the specific product, dose, and country. Approval for chronic weight management or type 2 diabetes does not automatically mean approval for knee osteoarthritis.

Using an approved medicine for a condition not listed on its label may be considered off-label prescribing. A clinician may consider this in some circumstances, but the decision requires an assessment of medical history, risks, benefits, alternatives, and eligibility.

Patients should not start semaglutide independently, borrow another person’s prescription, or change the dose without medical supervision. Unapproved or counterfeit products bought online may contain the wrong ingredient or concentration. Incorrect dosing can cause severe vomiting, dehydration, medication interactions, or other complications.

Side Effects and Safety Considerations

Common side effects of semaglutide can include:

• Nausea.
• Vomiting.
• Diarrhea.
• Constipation.
• Reduced appetite.
• Abdominal discomfort.

These effects may be more noticeable when the dose increases. A clinician may adjust the escalation schedule or pause treatment if symptoms are difficult to tolerate.

Potential serious concerns include gallbladder disease, pancreatitis, dehydration-related kidney problems, allergic reactions, and low blood sugar when semaglutide is combined with insulin or certain diabetes medicines.

People who are pregnant, planning pregnancy, or breastfeeding should seek specific medical advice before using weight-loss medication. Individuals with a history of pancreatitis, gallbladder disease, significant gastrointestinal problems, diabetes, or complex medication use also need careful evaluation.

Unexplained or rapidly worsening knee pain requires a separate assessment. A weight-loss medication should not delay evaluation of a potentially serious joint problem.

Established Treatments for Knee Osteoarthritis

Exercise and Physical Therapy

Exercise remains one of the most effective approaches for improving knee osteoarthritis function. A program may include strengthening, balance work, flexibility exercises, and low-impact aerobic activity.

Options can include walking at a tolerable pace, cycling, water exercise, quadriceps strengthening, hip-strengthening exercises, and range-of-motion exercises. A physical therapist can adapt the program for pain, weakness, limited mobility, or previous injury. Exercise should be paced appropriately rather than continued through severe or escalating pain.

Weight Management Without Medication

Nutrition support, sleep, behavior changes, and physical activity can contribute to sustainable weight management. Goals should reflect a person’s health, preferences, mobility, access to care, and long-term ability to maintain changes.

Medication can be part of a broader plan, but it does not replace movement, strength training, or support for healthy eating.

Pain-Relief Options

Topical or oral pain medicines may help some people. Suitability depends on kidney function, cardiovascular risk, gastrointestinal history, age, pregnancy status, and other medications.

Injections, braces, walking aids, and procedures may be considered after a clinical assessment. Surgery, including knee replacement, may be appropriate for advanced osteoarthritis when pain and disability remain substantial despite nonsurgical treatment.

Who Might Benefit Most?

The people most likely to match the study population are adults with obesity, painful knee osteoarthritis, and a medical indication for semaglutide. Potential benefits may include lower pain, improved mobility, weight reduction, and better metabolic health.

Treatment still requires individualized evaluation. Cost, access, insurance coverage, side effects, contraindications, and the possibility of long-term treatment all matter.

Seek medical care for sudden severe pain, a hot or red knee, acute swelling, fever, inability to bear weight after an injury, locking, major instability, or rapidly worsening symptoms. These signs can indicate infection, a fracture, a major injury, gout, inflammatory arthritis, or another condition.

What Researchers Still Need to Learn

Future research should determine:

• Whether pain relief continues beyond the study period.
• Whether symptoms return after treatment stops.
• Whether semaglutide changes the rate of joint deterioration.
• Whether treatment affects the need for knee replacement.
• How much benefit comes from weight loss versus direct metabolic effects.
• Whether similar benefits occur with other weight-loss drugs.
• Whether people without diabetes respond in the same way.
• Whether people with less severe obesity or advanced osteoarthritis benefit similarly.
• Whether the results apply broadly across different populations.

Researchers also need to compare medication-assisted weight loss with lifestyle-based weight loss and other obesity treatments.

Bottom Line

A major study suggests that semaglutide may reduce knee pain and improve physical function in some people with obesity and knee osteoarthritis. The likely benefits may come from substantial weight loss, reduced stress on the knee, improved mobility, and broader metabolic changes. Source 1

The medication should not be described as a universal cure, a proven cartilage-restoring treatment, or an approved osteoarthritis therapy unless regulators specifically authorize that use. Side effects, contraindications, cost, access, and long-term outcomes must be considered.

People with obesity and persistent knee pain should discuss evidence-based options with a qualified clinician rather than starting weight-loss medication independently.

Frequently Asked Questions

Can a weight-loss drug reduce knee pain?

A major study suggests that semaglutide may reduce knee pain in some people with obesity and osteoarthritis. The benefit may result from weight loss, lower joint loading, improved mobility, and metabolic changes. It may not help every cause of knee pain.

Does semaglutide repair damaged knee cartilage?

No. The reported pain and function improvements do not prove that semaglutide repairs cartilage or reverses osteoarthritis. Long-term imaging studies are needed to determine whether it changes joint structure.

Is semaglutide approved to treat knee osteoarthritis?

Semaglutide is approved for specific weight-management and diabetes indications, depending on the product and country. Those approvals do not automatically include knee osteoarthritis. Patients should confirm current regulatory status with a licensed healthcare professional.

How much weight must someone lose to improve knee pain?

No single amount guarantees pain relief. Benefits vary according to body weight, osteoarthritis severity, muscle strength, activity, joint damage, and other health conditions. A clinician or physical therapist can help establish a safe goal.

What are the main side effects of semaglutide?

Common side effects include nausea, vomiting, diarrhea, constipation, reduced appetite, and abdominal discomfort. Serious risks are medication-specific and may include gallbladder disease, pancreatitis, dehydration-related kidney problems, allergic reactions, and low blood sugar with certain diabetes medicines.

What can help knee osteoarthritis besides weight-loss medication?

Exercise, physical therapy, strength training, activity modification, weight management, pain medicines, injections, braces, walking aids, and surgery may be appropriate depending on severity. A personalized treatment plan is safer than relying on one medication alone.